Hypoxia as a target for combined modality treatments. (Q34501934)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11803141%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

review article

1 reference

title

Hypoxia as a target for combined modality treatments (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11803141%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11803141%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

Marianne Koritzinsky

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11803141%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

Sandra Nuyts

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11803141%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

author name string

S A Weppler

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11803141%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

W Landuyt

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11803141%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

J Theys

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11803141%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

R K Chiu

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11803141%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

P Lambin

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11803141%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

publication date

1 January 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11803141%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Cancer

6 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11803141%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

volume

38

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11803141%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11803141%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

page(s)

240-257

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11803141%20AND%20SRC:MED&resulttype=core&format=json

Intratumoral pO2-measurements as predictive assay in the treatment of carcinoma of the uterine cervix

6 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Intratumoral oxygen tension in metastatic melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Radiobiological and immunohistochemical assessment of hypoxia in human melanoma xenografts: acute and chronic hypoxia in individual tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Oxygenation of mammary tumors as evaluated by ultrasound-guided computerized-pO2-histography

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Hypoxic regions exist in human prostate carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Invasive oxygen measurements and pimonidazole labeling in human cervix carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

A comparison in individual murine tumors of techniques for measuring oxygen levels

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Direct relationship between radiobiological hypoxia in tumors and monoclonal antibody detection of EF5 cellular adducts

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Oxygenation of head and neck cancer: changes during radiotherapy and impact on treatment outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Oxygenation predicts radiation response and survival in patients with cervix cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Hypoxia in human soft tissue sarcomas: adverse impact on survival and no association with p53 mutations

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

The effect of hypoxia on the growth and radiation response of mammalian cells in culture

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Role of tumor vascular architecture in nutrient and drug delivery: an invasion percolation-based network model

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Hypoxia induces DNA overreplication and enhances metastatic potential of murine tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Relationship of hypoxia to metastatic ability in rodent tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Hypoxia-induced tumour cell migration in an in vivo chicken model.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Matrix metalloproteinases: molecular aspects of their roles in tumour invasion and metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Matrix metalloproteinase-1 is associated with poor prognosis in oesophageal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Tissue levels of matrix metalloproteinases MMP-2 and MMP-9 are related to the overall survival of patients with gastric carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Oxygen-mediated regulation of gelatinase and tissue inhibitor of metalloproteinases-1 expression by invasive cells

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Matrix metalloproteinase expression in cardiac myocytes following myocardial infarction in the rabbit

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Hypoxia-mediated stimulation of carcinoma cell invasiveness via upregulation of urokinase receptor expression

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Both increased stability and transcription contribute to the induction of the urokinase plasminogen activator receptor (uPAR) message by hypoxia

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Urokinase induces receptor mediated brain tumor cell migration and invasion.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Hypoxia facilitates tumour cell detachment by reducing expression of surface adhesion molecules and adhesion to extracellular matrices without loss of cell viability

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Cooperation between transcription factor AP-1 and NF-kappaB in the induction of interleukin-8 in human pancreatic adenocarcinoma cells by hypoxia

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Anoxia-induced up-regulation of interleukin-8 in human malignant melanoma. A potential mechanism for high tumor aggressiveness

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Estimating the selective advantage of mutant p53 tumour cells to repeated rounds of hypoxia.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Response of tumour cells to hypoxia: role of p53 and NFkB.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Regulation of hypoxia-induced angiogenesis: a chaperone escorts VEGF to the dance

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Hypoxia-induced metastasis of human melanoma cells: involvement of vascular endothelial growth factor-mediated angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

An FGF-binding protein (FGF-BP) exerts its biological function by parallel paracrine stimulation of tumor cell and endothelial cell proliferation through FGF-2 release

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Induction of the angiogenic modulator fibroblast growth factor-binding protein by epidermal growth factor is mediated through both MEK/ERK and p38 signal transduction pathways.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Selective activation of p38alpha and p38gamma by hypoxia. Role in regulation of cyclin D1 by hypoxia in PC12 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Hypoxia-mediated induction of acidic/basic fibroblast growth factor and platelet-derived growth factor in mononuclear phagocytes stimulates growth of hypoxic endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Hypoxia induces differential expression of the integrin receptors alpha(vbeta3) and alpha(vbeta5) in cultured human endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Role of alphavbeta3 integrin in the activation of vascular endothelial growth factor receptor-2.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Treatment outcome in advanced squamous cell carcinoma of the uterine cervix: relationships to pretreatment tumor oxygenation and vascularization

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

The relationship between tumor oxygenation and cell proliferation in human soft tissue sarcomas

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Tissue oxygen distribution in head and neck cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Oxygenation of squamous cell carcinoma of the head and neck: comparison of primary tumors, neck node metastases, and normal tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

A confirmatory prognostic study on oxygenation status and loco-regional control in advanced head and neck squamous cell carcinoma treated by radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Influence of the hypoxic subvolume on the survival of patients with head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Repeatability and prognostic impact of the pretreatment pO(2) histography in patients with advanced head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Tumour hypoxia and vascular density as predictors of metastasis in squamous cell carcinoma of the uterine cervix

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Hypoxia-induced treatment failure in advanced squamous cell carcinoma of the uterine cervix is primarily due to hypoxia-induced radiation resistance rather than hypoxia-induced metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Oxygen tension regulates the expression of the platelet-derived growth factor-B chain gene in human endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

The regulated expression of erythropoietin by two human hepatoma cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Oxygen-regulated control elements in the phosphoglycerate kinase 1 and lactate dehydrogenase A genes: similarities with the erythropoietin 3' enhancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Isoenzyme-specific regulation of genes involved in energy metabolism by hypoxia: similarities with the regulation of erythropoietin

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Regulation of c-jun expression during hypoxic and low-glucose stress

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Rabbit aortic endothelial cell hypoxia induces secretion of transforming growth factor beta and augments macrophage adhesion in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Regulation of angiogenic growth factor expression by hypoxia, transition metals, and chelating agents

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Hypoxia-induced pRB hypophosphorylation results from downregulation of CDK and upregulation of PP1 activities

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Hypoxic stabilization of vascular endothelial growth factor mRNA by the RNA-binding protein HuR

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Expression of the oxygen-regulated protein ORP150 accelerates wound healing by modulating intracellular VEGF transport.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Translation of vascular endothelial growth factor mRNA by internal ribosome entry: implications for translation under hypoxia

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Regulation of vascular endothelial growth factor (VEGF) expression is mediated by internal initiation of translation and alternative initiation of transcription.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

The vascular endothelial growth factor mRNA contains an internal ribosome entry site.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Hypoxia induces accumulation of p53 protein, but activation of a G1-phase checkpoint by low-oxygen conditions is independent of p53 status.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Activation of AP-1 and of a nuclear redox factor, Ref-1, in the response of HT29 colon cancer cells to hypoxia

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Nuclear factor interleukin 6 motifs mediate tissue-specific gene transcription in hypoxia

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Hypoxia-associated induction of early growth response-1 gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Hypoxia-inducible factor 1: control of oxygen homeostasis in health and disease

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

A 24-base-pair sequence 3' to the human erythropoietin gene contains a hypoxia-responsive transcriptional enhancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

A hypoxia-responsive element mediates a novel pathway of activation of the inducible nitric oxide synthase promoter

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Differential transcriptional regulation of the two vascular endothelial growth factor receptor genes. Flt-1, but not Flk-1/KDR, is up-regulated by hypoxia.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1 alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Regulation of transcription by hypoxia requires a multiprotein complex that includes hypoxia-inducible factor 1, an adjacent transcription factor, and p300/CREB binding protein

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Hypoxia-inducible factor 1alpha (HIF-1alpha) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions. Its stabilization by hypoxia depends on redox-induced changes

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

In vivo expression of mRNAs encoding hypoxia-inducible factor 1

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Regulation of hypoxia-inducible factor 1alpha is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Regulation of the hypoxia-inducible transcription factor 1alpha by the ubiquitin-proteasome pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Sensitization of hypoxic tumour cells--clinical experience

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Prognostic Value of Pretreatment Factors in Patients with Locally Advanced Carcinoma of the Uterine Cervix Treated by Radiotherapy Alone

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Prognostic value of hemoglobin concentrations and blood transfusions in advanced carcinoma of the cervix treated by radiation therapy: results of a retrospective study of 386 patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Prognostic factors for local and distant recurrence in Stage I and II cervical carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Pretreatment hemoglobin level influences local control and survival of T1-T2 squamous cell carcinomas of the glottic larynx

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Anemia is associated with decreased survival and increased locoregional failure in patients with locally advanced head and neck carcinoma: a secondary analysis of RTOG 85-27.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

The prognostic value of hemoglobin and a decrease in hemoglobin during radiotherapy in laryngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

T1/T2 glottic cancer managed by external beam radiotherapy: the influence of pretreatment hemoglobin on local control

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Anemia is associated with lower local-regional control and survival after radiation therapy for head and neck cancer: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Radiation myelitis and survival in the radiotherapy of lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Results of treatment and lessons learned from pathologically staged T4 non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

The effect of arterial oxygen content on the results of radiation therapy for epidermoid bronchogenic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Local control of muscle-invasive bladder cancer: preoperative radiotherapy and cystectomy versus cystectomy alone

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Blood tests and prognosis in bladder carcinomas treated with definitive radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

DNA Analysis in Predicting Survival of Irradiated Patients with Transitional Cell Carcinoma of Bladder

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Prognostic factors in patients with bladder carcinoma treated with definitive irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

The influence of initial hemoglobin and blood pressure levels on results of radiation therapy for carcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

The significance of anemia in clinical radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Impact of hemoglobin level and use of recombinant erythropoietin on efficacy of preoperative chemoradiation therapy for squamous cell carcinoma of the oral cavity and oropharynx

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Extrapolations from laboratory and preclinical studies for the use of carbogen and nicotinamide in radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Effect of nicotinamide on the microregional heterogeneity of oxygen delivery within a murine tumor

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Radiosensitization with normobaric oxygen and carbogen

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Changes in the oxygenation of head and neck tumors during carbogen breathing

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Reducing acute and chronic hypoxia in tumours by combining nicotinamide with carbogen breathing

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Carbogen breathing with nicotinamide improves the oxygen status of tumours in patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

The radiation response of KHT sarcomas following nicotinamide treatment and carbogen breathing

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

The effects of carbogen and nicotinamide on intravascular oxyhaemoglobin saturations in SCCVII and KHT murine tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Carbogen and nicotinamide as radiosensitizers in a murine mammary carcinoma using conventional and accelerated radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

ARCON--current status: summary of a workshop on preclinical and clinical studies

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Enhancement of tumor perfusion and oxygenation by carbogen and nicotinamide during single- and multifraction irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Accelerated radiotherapy with carbogen and nicotinamide (ARCON) for laryngeal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Clinical outcome and tumour microenvironmental effects of accelerated radiotherapy with carbogen and nicotinamide

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Hypoxic radiosensitizers in radical radiotherapy for patients with bladder carcinoma: hyperbaric oxygen, misonidazole, and accelerated radiotherapy, carbogen, and nicotinamide

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

ARCON: accelerated radiotherapy with carbogen and nicotinamide in head and neck squamous cell carcinomas. The experience of the Co-operative group of radiotherapy of the european organization for research and treatment of cancer (EORTC).

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

ARCON: accelerated radiotherapy with carbogen and nicotinamide in non small cell lung cancer: a phase I/II study by the EORTC.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Accelerated radiotherapy, carbogen, and nicotinamide in glioblastoma multiforme: report of European Organization for Research and Treatment of Cancer trial 22933.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Studies of the pharmacokinetic properties of nimorazole

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

A phase I clinical study of Nimorazole as a hypoxic radiosensitizer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

A randomized double-blind phase III study of nimorazole as a hypoxic radiosensitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma. Results of the Danish Head and Neck Cancer Study (DAHANCA) Protocol 5-85.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Tirapazamine plus cisplatin versus cisplatin in advanced non-small-cell lung cancer: A report of the international CATAPULT I study group. Cisplatin and Tirapazamine in Subjects with Advanced Previously Untreated Non-Small-Cell Lung Tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Phase I trial of concurrent tirapazamine, cisplatin, and radiotherapy in patients with advanced head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

A phase I/II evaluation of tirapazamine administered intravenously concurrent with cisplatin and radiotherapy in women with locally advanced cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

SR 4233 (tirapazamine): a new anticancer drug exploiting hypoxia in solid tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Cisplatin anti-tumour potentiation by tirapazamine results from a hypoxia-dependent cellular sensitization to cisplatin

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Potentiation of cisplatin activity by the bioreductive agent tirapazamine

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Tirapazamine with cisplatin in patients with advanced non-small-cell lung cancer: a phase II study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Phase II study of the combination of the novel bioreductive agent, tirapazamine, with cisplatin in patients with advanced non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

An investigation of the molecular basis for the synergistic interaction of tirapazamine and cisplatin

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

AQ4N: a new approach to hypoxia-activated cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

AQ4N: an alkylaminoanthraquinone N-oxide showing bioreductive potential and positive interaction with radiation in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Chemotherapeutic tumour targeting using clostridial spores

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Colonisation of Clostridium in the body is restricted to hypoxic and necrotic areas of tumours.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Lipid A mutant Salmonella with suppressed virulence and TNFalpha induction retain tumor-targeting in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Anaerobic bacteria as a gene delivery system that is controlled by the tumor microenvironment

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Specific targeting of cytosine deaminase to solid tumors by engineered Clostridium acetobutylicum.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

The use of radiation-induced bacterial promoters in anaerobic conditions: a means to control gene expression in clostridium-mediated therapy for cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Bifidobacterium longum as a delivery system for cancer gene therapy: selective localization and growth in hypoxic tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Evidence for characteristic vascular patterns in solid tumours: quantitative studies using corrosion casts

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Vascular attack as a therapeutic strategy for cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Endothelial-cell proliferation in experimental tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Tumor angiogenesis: therapeutic implications

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Matrix metalloproteinases regulate neovascularization by acting as pericellular fibrinolysins

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

The power of the front page of The New York Times

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppression

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Endostatin: an endogenous inhibitor of angiogenesis and tumor growth

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Thalidomide is an inhibitor of angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

The effect of thalidomide on experimental tumors and metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Phase II trial of the antiangiogenic agent thalidomide in patients with recurrent high-grade gliomas

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Nuclease-resistant synthetic ribozymes: developing a new class of therapeutics

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

An anti-human VEGF monoclonal antibody, MV833, that exhibits potent anti-tumor activity in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Anti-VEGF antibody treatment of glioblastoma prolongs survival but results in increased vascular cooption

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Definition of Two Angiogenic Pathways by Distinct alpha(v) Integrins

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Requirement of vascular integrin alpha v beta 3 for angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Antiintegrin alpha v beta 3 blocks human breast cancer growth and angiogenesis in human skin

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Alpha v integrins as receptors for tumor targeting by circulating ligands.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Stepwise in vitro affinity maturation of Vitaxin, an alphav beta3-specific humanized mAb.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Inhibition of angiogenesis in vivo by interleukin 12.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Interleukin-12 and interleukin-18 synergistically induce murine tumor regression which involves inhibition of angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Cytokines and soluble cytokine receptor induction after IL-12 administration in cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Vascular Endothelium as the Vulnerable Element in Tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Vinca alkaloids: anti-vascular effects in a murine tumour

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

The effect of combretastatin A-4 disodium phosphate in a C3H mouse mammary carcinoma and a variety of murine spontaneous tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

The use of vascularised spheroids to investigate the action of flavone acetic acid on tumour blood vessels

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Inhibition of growth of colon 38 adenocarcinoma by vinblastine and colchicine: evidence for a vascular mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Antineoplastic agents. 291. Isolation and synthesis of combretastatins A-4, A-5, and A-6(1a)

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Isolation and structure of the strong cell growth and tubulin inhibitor combretastatin A-4.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Targeting the tumor vasculature with combretastatin A-4 disodium phosphate: effects on radiation therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Vascular targeting of solid tumours: a major 'inverse' volume-response relationship following combretastatin A-4 phosphate treatment of rat rhabdomyosarcomas

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Transcription factor HIF-1 is a necessary mediator of the pasteur effect in mammalian cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Gene transfer of antisense hypoxia inducible factor-1 alpha enhances the therapeutic efficacy of cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Suppression of tumor growth through disruption of hypoxia-inducible transcription

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Histone deacetylases induce angiogenesis by negative regulation of tumor suppressor genes

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Enhancement of radiosensitivity by proteasome inhibition: implications for a role of NF-kappaB.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Proteasome inhibition: a new strategy in cancer treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Hypoxia modulated gene expression: angiogenesis, metastasis and therapeutic exploitation

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Targeting gene expression to hypoxic tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Enhancement of gene expression under hypoxic conditions using fragments of the human vascular endothelial growth factor and the erythropoietin genes

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Development of a hypoxia-responsive vector for tumor-specific gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Tumour microcirculation as a target for hyperthermia

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

1 reference

7 January 2021

Photodynamic therapy in oncology: mechanisms and clinical use.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

Tumor Infarction in Mice by Antibody-Directed Targeting of Tissue Factor to Tumor Vasculature

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900361-6

7 January 2021

10.1016/S0959-8049(01)00361-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11803141%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

1 reference